{
    "title": "Merck sees sharp decline in COVID sales for 2023 after strong fourth quarter",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11705749/Merck-forecasts-sharp-drop-COVID-antiviral-pill-sales-2023.html",
    "date": "2023-02-02",
    "keywords": [
        "year",
        "analyst",
        "quarter",
        "forecast",
        "molnupiravir",
        "asia",
        "cancer",
        "drug",
        "erman",
        "street",
        "decline",
        "share",
        "merck",
        "company",
        "japan",
        "co",
        "thursday",
        "treatment",
        "drugmaker",
        "fourthquarter",
        "profit",
        "covid",
        "pill",
        "blockbuster",
        "outlook",
        "estimate",
        "tax",
        "hit",
        "acquisition",
        "developer",
        "imago",
        "boost",
        "immunotherapy",
        "keytruda",
        "line",
        "executive",
        "rob",
        "davis",
        "wave",
        "brand",
        "name",
        "region",
        "strength",
        "demand",
        "lagevrio",
        "interview",
        "market",
        "leader",
        "use",
        "china",
        "factor",
        "papillomavirus",
        "hpv",
        "vaccine",
        "gardasil",
        "jersey",
        "leroy",
        "leo",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}